NasdaqGM - Nasdaq Real Time Price USD

Neuronetics, Inc. (STIM)

2.1600

-0.1800

(-7.69%)

At close: January 14 at 4:00:01 PM EST

2.1000

-0.06

(-2.78%)

After hours: 7:01:33 PM EST

Key Events

Loading Chart for STIM

9/21 12:03 PM

DELL

Previous Close 2.3400
Open 2.2200
Bid 2.1300 x 100
Ask 2.1900 x 100
Day's Range 1.9601 - 2.2390
52 Week Range 0.5200 - 5.0700
Volume 1,304,690
Avg. Volume 593,906
Market Cap (intraday) 120.209M
Beta (5Y Monthly) 2.22
PE Ratio (TTM) --
EPS (TTM) -1.2200
Earnings Date Jan 14, 2025 - Jan 17, 2025
Forward Dividend & Yield --
Ex-Dividend Date --
1y Target Est 2.67

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

203

Full Time Employees

December 31

Fiscal Year Ends

Sector

Diagnostics & Research

Industry

Trailing total returns as of 1/14/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

STIM

45.95%

S&P 500

1.08%

1-Year Return

STIM

28.95%

S&P 500

22.14%

3-Year Return

STIM

45.86%

S&P 500

25.41%

5-Year Return

STIM

48.82%

S&P 500

77.70%

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Neuronetics, Inc.

2.1600

-7.69%

Mkt Cap 120.209M

Industry Diagnostics & Research

4.2200

0.00%

Mkt Cap 135.104M

Industry Diagnostics & Research

1.2800

-14.67%

Mkt Cap 7.489M

Industry Diagnostics & Research

ProPhase Labs, Inc.

0.6055

-5.39%

Mkt Cap 14.456M

Industry Diagnostics & Research

Applied DNA Sciences, Inc.

0.1825

-5.64%

Mkt Cap 9.544M

Industry Diagnostics & Research

Personalis, Inc.

5.13

-4.11%

Mkt Cap 434.475M

Industry Diagnostics & Research

T2 Biosystems, Inc.

0.2900

-9.38%

Mkt Cap 6.102M

Industry Diagnostics & Research

bioAffinity Technologies, Inc.

0.7575

+0.37%

Mkt Cap 11.805M

Industry Diagnostics & Research

Exact Sciences Corporation

54.20

-7.37%

Mkt Cap 10.031B

Industry Diagnostics & Research

Mainz Biomed N.V.

5.29

+13.28%

Mkt Cap 11.752M

Industry Diagnostics & Research

NeoGenomics, Inc.

13.78

+9.11%

Mkt Cap 1.769B

Industry Diagnostics & Research

Valuation Measures

    Annual 

As of 1/13/2025

Market Cap

130.23M
Enterprise Value

157.48M
Trailing P/E

--
Forward P/E

--
PEG Ratio (5yr expected)

--
Price/Sales (ttm)

0.96
Price/Book (mrq)

13.88
Enterprise Value/Revenue

2.17
Enterprise Value/EBITDA

--

Financial Highlights

Profitability and Income Statement

Profit Margin

-45.06%
Return on Assets (ttm)

-16.90%
Return on Equity (ttm)

-100.13%
Revenue (ttm)

72.06M
Net Income Avi to Common (ttm)

-32.47M
Diluted EPS (ttm)

-1.2200

Balance Sheet and Cash Flow

Total Cash (mrq)

42.64M
Total Debt/Equity (mrq)

323.03%
Levered Free Cash Flow (ttm)

-15.35M

KZR Kezar Life Sciences, Inc.

6.21

-1.43%

VRCA Verrica Pharmaceuticals Inc.

0.6557

+3.26%

SIBN SI-BONE, Inc.

15.70

-3.27%

STRO Sutro Biopharma, Inc.

1.7200

-3.91%

EVLO Evelo Biosciences, Inc.

0.0005

0.00%

SYBX Synlogic, Inc.

1.4400

+1.41%

OPTN OptiNose, Inc.

5.0000

-0.40%

APYX Apyx Medical Corporation

1.4300

-4.03%

YMAB Y-mAbs Therapeutics, Inc.

6.33

-2.62%

TRVI Trevi Therapeutics, Inc.

3.9300

-1.50%

CELC Celcuity Inc.

10.53

-2.95%

REPL Replimune Group, Inc.

10.49

-3.67%

MRSN Mersana Therapeutics, Inc.

0.6340

+2.01%

LQDA Liquidia Corporation

11.36

-3.40%

SRRK Scholar Rock Holding Corporation

41.53

-2.51%

SLDB Solid Biosciences Inc.

3.0900

-6.65%